Samuel Goldwyn Films Acquires WWII Drama ‘The Last Rifleman’ Starring Pierce Brosnan
EXCLUSIVE: Samuel Goldwyn Films has acquired North American rights to The Last Rifleman, a WWII veteran drama starring Pierce Brosnan (The Great Lillian Hall).
Written by Kevin Fitzpatrick and directed by Terry Loane, the film will be released in theaters on November 8. Other titles set for that frame include Focus Features’ awards prospect Conclave from Edward Berger, Lionsgate’s family comedy The Best Christmas Pageant Ever, Vertical’s sci-fi thriller Elevation starring Anthony Mackie and Morena Baccarin, and Sony/Crunchyroll’s Overlord: The Sacred Kingdom.
More from Deadline
Christian Petzold Drama ‘Miroirs No. 3’ Lands North American Distribution With Metrograph
Halle Berry On Why Her 'Die Another Day' Co-Star Pierce Brosnan "Will Always Be My Bond"
Inspired by a true story, The Last Rifleman centers on Brosnan’s Artie Crawford, a World War II veteran living in a care home in Northern Ireland who has just lost his wife. On the 75th anniversary of the D-Day landings, he decides to escape his care home and embarks on a journey to France to pay his final respects.
Pic’s ensemble also features Clémence Poésy (The Walking Dead: Daryl Dixon), John Amos (Me Time), Ian McElhinney (The Boys in the Boat) and Desmond Eastwood (Normal People). Katy Jackson and John Leslie produced for Wee Buns (Zoo), with Jacqueline Kerrin and Dominic Wright from Ripple World Pictures (Never Grow Old) co-producing. Oscar nominee Mark Huffam (The Martian), Kevin Jackson (Zoo), Nick Leese, Eloise Singer (Rare Beasts) and Tommy Curran served as executive producers.
Stated Samuel Goldwyn Films’ President, Peter Goldwyn, who negotiated the acquisition deal with Maya Amsellem from WestEnd on behalf of the producers, “We’re thrilled to bring this heartwarming and poignant story of a war veteran to audiences in the U.S. We’re confident this crowd-pleasing true story will have universal appeal across the whole country.”
Sign up for Deadline's Newsletter. For the latest news, follow us on Facebook, Twitter, and Instagram.